Keith Syson Chan

2004-2009 Stem Cell & Regenerative Medicine Center Stanford University, Palo Alto, CA 
 2016- Baylor College of Medicine, Houston, TX 
 2019- Cedars-Sinai Medical Center, Los Angeles, CA, United States 
"Keith Syson Chan"
Mean distance: (not calculated yet)


Sign in to add mentor
John DiGiovanni grad student 2004 The University of Texas Graduate School of Biomedical Sciences at Houston (Chemistry Tree)
 (Significance of signal transducer and activator of transcription 3 during multistage mouse skin carcinogenesis.)
Irving L. Weissman post-doc 2004-2009 Stanford (FlyTree)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Broz MT, Ko EY, Ishaya K, et al. (2024) Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomas. Nature Communications. 15: 2498
Heiser CN, Simmons AJ, Revetta F, et al. (2023) Molecular cartography uncovers evolutionary and microenvironmental dynamics in sporadic colorectal tumors. Cell. 186: 5620-5637.e16
Riveros C, Ranganathan S, Haque W, et al. (2023) Comparative real-world survival outcomes of muscle-invasive bladder cancer treated with bladder-only vs. whole-pelvis concurrent chemoradiation. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
Piras R, Ko EY, Barrett C, et al. (2022) circCsnk1g3- and circAnkib1-regulated interferon responses in sarcoma promote tumorigenesis by shaping the immune microenvironment. Nature Communications. 13: 7243
You S, Kim M, Hoi XP, et al. (2022) Discoidin domain receptor-driven gene signatures as markers of patient response to anti-PD-L1 immune checkpoint therapy. Journal of the National Cancer Institute
Lee YC, Lam HM, Rosser C, et al. (2022) The dynamic roles of the bladder tumour microenvironment. Nature Reviews. Urology
You S, Kim M, Widen S, et al. (2022) Characterizing molecular subtypes of high-risk non-muscle-invasive bladder cancer in African American patients. Urologic Oncology
Nikolos F, Hayashi K, Hoi XP, et al. (2022) Cell death-induced immunogenicity enhances chemoimmunotherapeutic response by converting immune-excluded into T-cell inflamed bladder tumors. Nature Communications. 13: 1487
Tyner JW, Haderk F, Kumaraswamy A, et al. (2022) Understanding Drug Sensitivity and Tackling Resistance in Cancer. Cancer Research
Pollan SG, Teng PC, Jan YJ, et al. (2021) Loss of CDCP1 triggers FAK activation in detached prostate cancer cells. American Journal of Clinical and Experimental Urology. 9: 350-366
See more...